London, UK, and San Diego, CA: 16 April 2008 - Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that new preclinical data on its anti-nucleolin aptamer drug AS1411 are presented today at the American Association for Cancer Research (AACR) meeting in San Diego, CA.
